• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响犬肥大细胞瘤组织学分级和有丝分裂指数的患者和肿瘤因素。

Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index.

机构信息

Department of Oncology, Animal Referral Hospital Brisbane, Brisbane, Queensland, Australia.

Discipline of Veterinary Sciences, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, Australia.

出版信息

Vet Comp Oncol. 2019 Sep;17(3):338-344. doi: 10.1111/vco.12477. Epub 2019 Apr 25.

DOI:10.1111/vco.12477
PMID:30891882
Abstract

The aim of this study was to identify patient and tumour factors most frequently associated with high histological grades of canine mast cell tumours (MCTs). Search criteria in a shared database of multiple Animal Referral Hospital locations within Australia generated 400 canine MCTs in 286 patients. Patient and tumour data were extrapolated and the association between a tumour being histologically high grade and patient and tumour factors, including: patient breed, patient gender and neuter status, patient age at MCT excision, tumour location and tumour size was assessed using univariate analysis. The study consisted of 90 (21.9%) tumours meeting histological high-grade criteria. Shar peis were the most likely breed to have high grade MCTs, whereas the Pug and the Golden Retriever were the least likely breeds to develop high-grade MCTs. No significant difference in risks could be established between the age at which the tumour was excised, or the gender and neuter status of patients. MCTs of the inguinal region were the most likely single location to be high grade. Tumour size did not influence the likelihood of a tumour being high grade or low grade. The results of this study suggest that patient and tumour factors may play a role in the histological grades of canine MCTs.

摘要

本研究旨在确定与犬肥大细胞瘤(MCT)高组织学分级最相关的患者和肿瘤因素。在澳大利亚多个动物转诊医院的共享数据库中进行搜索,生成了 286 名患者的 400 例犬 MCT。提取患者和肿瘤数据,并使用单因素分析评估肿瘤的组织学高分级与患者和肿瘤因素之间的关系,包括:患者品种、患者性别和绝育状态、MCT 切除时的患者年龄、肿瘤位置和肿瘤大小。该研究包括 90 例(21.9%)符合组织学高分级标准的肿瘤。设得兰牧羊犬是最有可能患有高分级 MCT 的品种,而哈巴狗和金毛寻回犬是最不可能发展为高分级 MCT 的品种。肿瘤切除时的年龄、患者的性别和绝育状态之间的风险无显著差异。腹股沟区的 MCT 是最有可能为高分级的单一部位。肿瘤大小不影响肿瘤为高分级或低分级的可能性。本研究结果表明,患者和肿瘤因素可能在犬肥大细胞瘤的组织学分级中起作用。

相似文献

1
Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index.影响犬肥大细胞瘤组织学分级和有丝分裂指数的患者和肿瘤因素。
Vet Comp Oncol. 2019 Sep;17(3):338-344. doi: 10.1111/vco.12477. Epub 2019 Apr 25.
2
Epidemiological Study of Canine Mast Cell Tumours According to the Histological Malignancy Grade.根据组织学恶性程度对犬肥大细胞瘤的流行病学研究
Pol J Vet Sci. 2017 Sep 26;20(3):455-465. doi: 10.1515/pjvs-2017-0055.
3
Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.澳大利亚犬肥大细胞瘤中C-KIT原癌基因第11外显子内部串联重复的患病率。
Aust Vet J. 2017 Oct;95(10):386-391. doi: 10.1111/avj.12636.
4
Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.基于基佩尔两级恶性分类法的犬肥大细胞瘤风险的流行病学评估。
Acta Vet Scand. 2018 Nov 3;60(1):70. doi: 10.1186/s13028-018-0424-2.
5
Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000-2010.奥地利犬肥大细胞瘤的品种相关优势比及解剖分布。对2000年至2010年病例的回顾性研究。
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2014;42(6):367-73. doi: 10.15654/TPK-140165. Epub 2014 Nov 24.
6
Association of breed and histopathological grade in canine mast cell tumours.犬肥大细胞瘤的品种与组织病理学分级的关联
Vet Comp Oncol. 2017 Sep;15(3):829-839. doi: 10.1111/vco.12225. Epub 2016 May 19.
7
Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.评估组织学分级和组织学无肿瘤切缘作为完全切除的犬肥大细胞瘤局部复发预测指标的研究。
Vet Comp Oncol. 2015 Mar;13(1):70-6. doi: 10.1111/vco.12021. Epub 2013 Mar 4.
8
Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.犬肥大细胞瘤中纤维母细胞激活蛋白的表达及其与组织学分级、有丝分裂指数和Ki67表达的相关性
J Comp Pathol. 2017 Jan;156(1):14-20. doi: 10.1016/j.jcpa.2016.10.004. Epub 2016 Nov 24.
9
Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom.犬肥大细胞瘤的品种易感性:英国单中心经验。
Vet J. 2013 Aug;197(2):496-8. doi: 10.1016/j.tvjl.2013.02.017. Epub 2013 Apr 9.
10
Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.有丝分裂指数与Ki67指数在犬皮肤肥大细胞瘤预后评估中的比较
Vet Comp Oncol. 2015 Jun;13(2):143-50. doi: 10.1111/vco.12029. Epub 2013 Mar 12.

引用本文的文献

1
Stereological estimation of mean nuclear volume as a prognostic factor in canine subcutaneous mast cell tumors.作为犬皮下肥大细胞瘤预后因素的平均核体积的体视学估计
Vet Pathol. 2025 May;62(3):284-292. doi: 10.1177/03009858251315094. Epub 2025 Feb 19.
2
Response to tigilanol tiglate in dogs with mast cell tumors.对患有肥大细胞瘤的犬用替吉利兰替加特的反应。
J Vet Intern Med. 2024 Nov-Dec;38(6):3162-3169. doi: 10.1111/jvim.17211. Epub 2024 Oct 17.
3
Immunohistochemical and Molecular Genetic Analysis of Canine Digital Mast Cell Tumours.
犬趾部肥大细胞肿瘤的免疫组织化学和分子遗传学分析
Animals (Basel). 2023 May 19;13(10):1694. doi: 10.3390/ani13101694.
4
Canine mast cell tumors: When to worry about aggressive behavior pre-surgically.犬肥大细胞瘤:术前何时应担忧侵袭性行为。
Can Vet J. 2022 Dec;63(12):1261-1263.
5
Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study.犬皮肤肥大细胞瘤短疗程抗炎泼尼松治疗前后肿瘤分级及增殖指数的评估:一项初步研究
Vet Sci. 2022 Jun 7;9(6):277. doi: 10.3390/vetsci9060277.
6
Canine mast cell tumours part I: Clinical and survival outcomes.犬肥大细胞瘤第一部分:临床和生存结果。
Vet Med Sci. 2022 Jul;8(4):1409-1420. doi: 10.1002/vms3.812. Epub 2022 May 3.
7
Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate.用替吉兰诺醇酯对18例经细胞学诊断的犬高级别肥大细胞瘤进行瘤内治疗。
Front Vet Sci. 2021 Aug 27;8:675804. doi: 10.3389/fvets.2021.675804. eCollection 2021.